Neurol. praxi. 2015;16(3):155-158

Pregabalin in treatment of neuropathic pain

MUDr. Petr Sperling
Neurologická ambulance Přerov

Neuropathic pain is defined as a pain arising as a direct consequence of a lesion or disease affecting the somatosensory system (Treede, 2008). According to the anatomical localization neuropathic pain can be sorted into central and peripheral and then by etiology. In some cases there can occur both nociceptive and neuropathic component. Neuropathic pain has its specific symptoms and in contrast to nociceptive pain does not require the stimulation of pain receptors, though stimulation of nociceptive receptors can cause or emphasize the neuropathic pain. For patients, it is a symptom that persists and can significantly limit daily life. Therapy of neuropatic pain is complicated and should always be carefully and individually chosen. In terms of pharmacotherapy, antidepressants (SNRI serotonin–norepinephrine reuptake inhibitors and TCA tricyclic antidepressants) and antiepileptics (modulators of α2δ subunit of voltage-gated calcium channels) are recommended as first line therapy and opioids as second line therapy. The two case reports represent patients with neuropathic pain of diabetic origin in the first case and of spinal origin in the second case. These are the ones of the most common types of peripheral neuropathic pain. In both cases pregabalin was chosen as a therapy, in various schemes. Both patients rated the treatment positively, reported a significant improvement of their conditions. However, the treatment was always complete, it was necessary to carefully and gradually titrate the dose or choose a combination of drugs. In the second case, it was included interventional treatment solution.

Keywords: neuropathic pain, proximal diabetic neuropathy, plexo-radiculopathy, adjuvant analgesics, pregabalin

Published: June 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sperling P. Pregabalin in treatment of neuropathic pain. Neurol. praxi. 2015;16(3):155-158.
Download citation

References

  1. Ambler Z. Neuropatická bolest. Mechanismus, příčiny a možnosti farmakoterapie. Neurol. praxi, 2007; 2:107-110.
  2. Ambler Z. Neuropatická bolest - častá komponenta mnoha onemocnění. Neurol. praxi 2011; 12(5): 329-333.
  3. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Čes a Slov Neurol Neurochir 2002; 65/98: 135-138.
  4. Attal N. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, 2010; 17(9): 1113-e88.
  5. Backonja MM, Serra J. Pharmacologic management part 1: Better - studied neuropathic pain diseases. Pain Med 2004; 5: S28-47. Go to original source... Go to PubMed...
  6. Backonja MM, Serra J. Pharmacologic management part 2: Lesser - studied neuropathic pain diseases. Pain Med 2004; 5: S47-59. Go to original source... Go to PubMed...
  7. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807-819. Go to original source... Go to PubMed...
  8. Bednarik J, Vlckova - Moravcova E, Bursova S, Belobradkova J, Dusek L, Sommer C. Etiology of small-fiber neuropathy. J Peripher Nerv Syst 2009; 14: 177-183. Go to original source... Go to PubMed...
  9. Bednařík J. Reprint farmakoterapie neuropatické bolesti ve světle medicíny založené na důkazech. Bolest 2014; 2: 41-46.
  10. Bednařík J, Klinický standard pro farmakoterapii neuropatické bolesti. Cesk Slov Neurol N 2012; 75/108(1): 93-101.
  11. Berger A, Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004; 5(3): 143-149. Go to original source... Go to PubMed...
  12. ČNS Česká neurologická společnost, Klinický standard pro farmakoterapii neuropatické bolesti, 2011, http://www.czech-neuro.cz/rubrika/53-Doporucene-postupy-a-registry.
  13. Freynhagen R. The evaluation of neuropathic components in low back pain. See comment in PubMed Commons belowCurr Pain Headache Rep. 2009; 13(3): 185-190. Go to original source... Go to PubMed...
  14. Opavský J. Neuropatické bolesti - patofyziologické mechanizmy a principy terapie. Neurol. praxi 2006; 5: 270-274.
  15. Treede, Jensen TS, Campbell JN, Gruccu G, Dostrovskij JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes, Neurology. 2008; 70(18): 1630-1635. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.